Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Sell
662,928
-44,334
-6% -$1.16M 0.24% 48
2026
Q1
$19.9M Sell
707,262
-76,553
-10% -$2.04M 0.35% 45
2025
Q4
$19.5M Sell
783,815
-54,878
-7% -$1.38M 0.33% 47
2025
Q3
$21.4M Sell
838,693
-640,769
-43% -$15.8M 0.37% 43
2025
Q2
$35.9M Sell
1,479,462
-65,193
-4% -$1.52M 0.65% 38
2025
Q1
$39.1M Sell
1,544,655
-115,872
-7% -$3.03M 0.81% 36
2024
Q4
$44.1M Buy
1,660,527
+157,298
+10% +$4.27M 0.87% 36
2024
Q3
$43.5M Sell
1,503,229
-185,506
-11% -$5.41M 0.89% 35
2024
Q2
$47.3M Buy
1,688,735
+114,948
+7% +$3.16M 1.06% 29
2024
Q1
$43.7M Buy
1,573,787
+160,164
+11% +$4.44M 1.03% 29
2023
Q4
$40.6M Sell
1,413,623
-62,989
-4% -$1.9M 1.37% 23
2023
Q3
$1.47B Buy
1,476,612
+126,228
+9% +$4.46M 5.81% 2
2023
Q2
$1.34B Buy
1,350,384
+65,426
+5% +$2.55M 5.2% 3
2023
Q1
$1.28B Sell
1,284,958
-50,677
-4% -$2.19M 4.9% 4
2022
Q4
$68.4M Buy
1,335,635
+24,832
+2% +$1.19M 2.25% 14
2022
Q3
$57.4M Buy
1,310,803
+53,547
+4% +$2.6M 2.06% 17
2022
Q2
$65.9M Buy
1,257,256
+77,636
+7% +$3.96M 2.23% 14
2022
Q1
$61.1M Buy
1,179,620
+24,130
+2% +$1.25M 1.66% 19
2021
Q4
$65.5M Buy
1,155,490
+168,009
+17% +$8.32M 1.71% 16
2021
Q3
$42.5M Buy
987,481
+17,177
+2% +$761K 1.18% 22
2021
Q2
$38M Buy
970,304
+23,083
+2% +$898K 1.09% 26
2021
Q1
$34.3M Sell
947,221
-44,197
-4% -$1.57M 1.09% 25
2020
Q4
$36.5M Sell
991,418
-7,286
-0.7% -$267K 1.25% 23
2020
Q3
$34.8M Buy
998,704
+41,055
+4% +$1.44M 1.38% 21
2020
Q2
$29.7M Buy
957,649
+96,453
+11% +$3.28M 1.46% 19
2020
Q1
$26.7M Buy
861,196
+70,743
+9% +$2.41M 1.76% 17
2019
Q4
$29.4M Buy
+790,453
New +$28.2M 1.72% 12

Other funds holding PFE

Quilter Plc's PFE Position: Q2 2026 in Review

Quilter Plc reduced its Pfizer (PFE) stake by 6.3% in Q2 2026, selling an estimated $1.16M and leaving 662,928 shares worth $16M. The position accounts for 0.24% of the portfolio, ranked #48.

Quilter Plc first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.47B in Q3 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Quilter Plc held 662,928 shares of Pfizer worth $16M as of Q2 2026.
  • Quilter Plc sold 44,334 Pfizer shares in Q2 2026, an estimated $1.16M.
  • Pfizer made up 0.24% of Quilter Plc's portfolio in Q2 2026, its #48 holding.
  • Quilter Plc first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Quilter Plc's Pfizer position peaked at $1.47B in Q3 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quilter Plc's 13F filing for Q2 2026, filed 24 Jul 2026.